Anti-MUC13 antibody
产品特性
| Product Cat#: | AB-07-0846 |
| Immunogen: | A synthetic peptide derived from human MUC13. The exact amino-acid sequence is proprietary. |
| Antigen: | MUC13 |
| Product type: | Primary antibody |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | ELISA (1:5000); Western Blot (1:500~1:3000); Immunohistochemistry (1:50~1:100); Immunofluorescence (1:100~1:500) |
| Reactivity: | Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Antigen affinity chromatography |
| Storage: | Aliquot and freeze at -20°C. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Mucin-13 [Precursor]; Down-regulated in colon cancer 1; MUC13; DRCC1; RECC; UNQ6194/PRO20221 |
展开
靶标信息
Receptor involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. May play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation.
产品来源
洱畔科技实验室
